Psychopharmacology is the scientific study of the use of pharmacological compounds in the treatment of mental disorders. Physicians and other prescribers with expertise in psychopharmacology apply their knowledge of pharmacokinetics (what the body does to medication) and pharmacodynamics (what the medications do to the body) in finding optimal medication regimens in treating mental health conditions such as depression, bipolar disorder, schizophrenia, post-traumatic stress disorder, etc.
OUR MEETINGS
ASCP organizes three major meetings per year. The Fall and Spring Update on Psychopharmacology: State of the Art meetings (East and West coast) bring together a number of outstanding psychopharmacologists to educate participants about the latest developments in the field.
The ASCP Annual Meeting brings together over 1200 academic and industry investigators, research pharmacists, clinicians and representatives from regulatory agencies to discuss newer treatments and facilitate collaborations.
For the 2024 Annual Meeting, ASCP is pleased to offer these plenary sessions and welcome these plenary speakers:
Clinical Updates in Neurotherapeutics | WEDNESDAY, MAY 29
- Jeffrey Newcorn M.D. | Icahn School of Medicine At Mount Sinai
- Mark Pollack M.D. | Biopharmaceutical Consulting
- Julia Riddle M.D. | University of North Carolina at Chapel Hill
Update from Federal and Other Funding Agencies | THURSDAY, MAY 30
- Lori Davis M.D. | Veterans Affairs Medical Center
- Daniel Falk Ph.D. | NIAAA/NIH
- Fuad Issa M.D. | Defense Health Agency
- Ivan Montoya M.D.,M.P.H. | DHHS/National Institute on Drug Abuse
- Christopher Sarampote Ph.D. | National Institute of Mental Health
- Yu-Ping Wang M.D.,Other,M.Sc. Patient-Centered Outcomes Research Institute (PCORI)
Innovations in Clinical Research | THURSDAY, MAY 30
- Paul Kenny Ph.D. | Icahn School of Medicine at Mount Sinai
- Martina Pavlicova Ph.D. | Columbia University Medical Center
- Oleg Tcheremissine M.D. | Atrium Health
Regulatory Plenary | WEDNESDAY, MAY 29
- Teresa Buracchio M.D. | Center for Drug Evaluation and Research, Food and Drug Administration
- Michelle Campbell Ph.D. | Center for Drug Evaluation and Research, Food and Drug Administration
- Valentina Mantua M.D. | Center for Drug Evaluation and Research, Food and Drug Administration
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The Journal of Clinical Psychiatry
JCP is an international peer-reviewed journal and the official publication of the ASCP. Founded in 1939, the journal is the leading resource providing clinical information on mental health topics to psychiatrists and other medical professionals while exploring newest advances in diagnosis and treatment. Current ASCP members receive an online subscription to the journal at Psychiatrist.com as part of their membership.
ASCP MEMBERSHIP
Founded in 1992, American Society of Clinical Psychopharmacology (ASCP) is a premier organization that works to advance the science, education and practice of clinical psychopharmacology. It comprises of over 1,200 members from all regions of the world, who are advocates for rational clinical psychopharmacology and for clinical research to develop better treatments to treat mental health conditions.